Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01619384 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Stress Reduction and the Microbiome

A NA study of Post Traumatic Stress Disorder and Irritable Bowel Syndrome, sponsored by Seattle Institute for Biomedical and Clinical Research.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT01619384: Completed NA study of Post Traumatic Stress Disorder and Irritable Bowel Syndrome, sponsored by Seattle Institute for Biomedical and Clinical Research.

NCT01619384 is a NA study of Post Traumatic Stress Disorder and Irritable Bowel Syndrome that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 55 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01619384, a NA study of Post Traumatic Stress Disorder and Irritable Bowel Syndrome, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This proposed study aims to determine whether decreasing stress levels in persons with posttraumatic stress disorder (PTSD) can lead to a change in the intestinal microbiota, assessed 8 weeks after enrollment.

Primary Outcome

characterization of the intestinal microbiome is a primary endpoint

Interventions

  • BEHAVIORAL Mindfulness-Based Stress Reduction

Study Locations (1)

Washington

  • VA Puget Sound - Seattle

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2010-07
Est. Completion 2013-12
Phase NA

What the finished NCT01619384 record still lists

NCT01619384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-Based Stress Reduction is the first listed.

NCT01619384 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01619384 about?

NCT01619384 is a clinical study titled "Mindfulness-Based Stress Reduction and the Microbiome". This proposed study aims to determine whether decreasing stress levels in persons with posttraumatic stress disorder (PTSD) can lead to a change in the intestinal microbiota, assessed 8 weeks after enrollment.

What is the current status of trial NCT01619384?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2010-07. Estimated completion is 2013-12.

What conditions does trial NCT01619384 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Irritable Bowel Syndrome.

What interventions are being tested in trial NCT01619384?

The interventions under investigation include: Mindfulness-Based Stress Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01619384?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01619384 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01619384's enrollment target sits among peer trials

55 171st of 262 higher than 91 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01619384, the US trial registry maintained by the National Library of Medicine. NCT01619384 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.